Literature DB >> 32079017

Global, Regional and Country-Specific Burden of Ischaemic Stroke, Intracerebral Haemorrhage and Subarachnoid Haemorrhage: A Systematic Analysis of the Global Burden of Disease Study 2017.

Rita V Krishnamurthi1, Takayoshi Ikeda2, Valery L Feigin2.   

Abstract

BACKGROUND: Stroke is a leading cause of death and disability in globally and particularly in low- and middle-income countries, and this burden is increasing. The burden of stroke pathological subtypes varies in terms of incidence, disability and mortality. Previous Global Burden of Diseases, Injuries, and Risk Factors Studies (GBD) reports did not provide separate global burden and trends estimates for haemorrhagic stroke by primary intracerebral haemorrhage (PICH) and subarachnoid haemorrhage (SAH). AIM: To summarise the GBD 2017 findings for the burden and 27-year trends for ischaemic stroke (IS), intracerebral haemorrhage and SAH by age, sex and country income level in 21 world regions and associated risk factors.
METHODS: Data on stroke incidence, prevalence, mortality and disability-adjusted life-years (DALY) lost and the burden of IS, PICH and SAH were derived from all available datasets from the GBD 2017 studies. Data were analysed in terms of absolute numbers and age-standardised rates per 100,000 (95% uncertainty interval [UI]), with estimates stratified by age, sex and economic development level by the World Bank classification. We also analysed changes in the patterns of incidence, mortality and DALYs estimates between 1990 and 2017.
RESULTS: In 2017, there were 11.9 million incident (95% UI 11.1-12.8), 104.2 million prevalent (98.6-110.2), 6.2 million fatal (6.0-6.3) cases of stroke and 132.1 million stroke-related DALYs (126.5-137.4). Although stroke incidence, prevalence, mortality and DALY rates declined from 1990 to 2017, the absolute number of people who developed new stroke, died, survived or remained disabled from stroke has almost doubled. The bulk of stroke burden (80% all incident strokes, 77% all stroke survivors, 87% of all deaths from stroke and 89 of all stroke-related DALYs) in 2017 was in low- to middle-income countries. Globally in 2017, IS constituted 65%, PICH -26% and SAH -9% of all incident strokes. DISCUSSION: The latest GBD estimates of stroke burden in 195 countries supersede previous GBD stroke burden findings and provide most accurate data for stroke care planning and resource allocation globally, regionally and for 195 countries. Stroke remains the second leading cause of deaths and disability worldwide. The increased stroke burden continues to exacerbate a huge pressure on people affected by stroke, their families and societies. It is imperative to develop and implement more effective primary prevention strategies to reduce stroke burden and its impact.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Global Burden of Diseases, Injuries and Risk Factors Study 2017; Global burden; Stroke subtypes

Mesh:

Year:  2020        PMID: 32079017     DOI: 10.1159/000506396

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  109 in total

1.  Disability Status and Its Influencing Factors Among Stroke Patients in Northeast China: A 3-Year Follow-Up Study.

Authors:  Yumei Lv; Qiuxue Sun; Juan Li; Wenyue Zhang; Yudi He; Yuqiu Zhou
Journal:  Neuropsychiatr Dis Treat       Date:  2021-08-07       Impact factor: 2.570

2.  Feasibility of a pilot study on point-of-care biomarkers in spontaneous intracerebral hemorrhage in an emergency setting.

Authors:  Eugenia-Maria Mureşan; Adela Golea; Sorana D Bolboacă; Lăcrămioara Perju-Dumbravă
Journal:  Med Pharm Rep       Date:  2021-07-29

Review 3.  Role of lncRNAs in the Development of Ischemic Stroke and Their Therapeutic Potential.

Authors:  Kanika Vasudeva; Anyeasha Dutta; Anjana Munshi
Journal:  Mol Neurobiol       Date:  2021-04-05       Impact factor: 5.590

4.  Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies.

Authors:  Linxin Li; Michael T C Poon; Neshika E Samarasekera; Luke A Perry; Tom J Moullaali; Mark A Rodrigues; James J M Loan; Jacqueline Stephen; Christine Lerpiniere; Maria A Tuna; Sergei A Gutnikov; Wilhelm Kuker; Louise E Silver; Rustam Al-Shahi Salman; Peter M Rothwell
Journal:  Lancet Neurol       Date:  2021-06       Impact factor: 59.935

5.  Herbal medicine for post-stroke insomnia: A protocol for systematic review and meta-analysis.

Authors:  Sang-Ho Kim; Jung-Hwa Lim
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

Review 6.  Neuroprotective Role of Acidosis in Ischemia: Review of the Preclinical Evidence.

Authors:  Jeff Ehresman; Ethan Cottrill; Justin M Caplan; Cameron G McDougall; Nicholas Theodore; Paul A Nyquist
Journal:  Mol Neurobiol       Date:  2021-10-04       Impact factor: 5.590

7.  Repetitive Peripheral Sensory Stimulation as an Add-On Intervention for Upper Limb Rehabilitation in Stroke: A Randomized Trial.

Authors:  Adriana B Conforto; André G Machado; Nathalia H V Ribeiro; Ela B Plow; Sook-Lei Liew; Claudia da Costa Leite; Artemis Zavaliangos-Petropulu; Isabella Menezes; Sarah M Dos Anjos; Rafael Luccas; Paul Hunter Peckham; Leonardo G Cohen
Journal:  Neurorehabil Neural Repair       Date:  2021-09-29       Impact factor: 3.919

8.  Acute intracerebral haemorrhage: diagnosis and management.

Authors:  Iain J McGurgan; Wendy C Ziai; David J Werring; Rustam Al-Shahi Salman; Adrian R Parry-Jones
Journal:  Pract Neurol       Date:  2020-12-07

Review 9.  How cytosolic compartments play safeguard functions against neuroinflammation and cell death in cerebral ischemia.

Authors:  Fari Ryan; Seyed Esmaeil Khoshnam; Fariba Khodagholi; Ghorbangol Ashabi; Abolhassan Ahmadiani
Journal:  Metab Brain Dis       Date:  2021-06-26       Impact factor: 3.584

10.  Effectiveness of Rehabilitation Nursing versus Usual Therapist-Led Treatment in Patients with Acute Ischemic Stroke: A Randomized Non-Inferiority Trial.

Authors:  Jianmiao Wang; Yuping Zhang; Yuanyuan Chen; Mei Li; Hongyan Yang; Jinhua Chen; Qiaomin Tang; Jingfen Jin
Journal:  Clin Interv Aging       Date:  2021-06-21       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.